Ovid Therapeutics Inc (NASDAQ:OVID)

2.17
Delayed Data
As of 3:59pm ET
 -0.08 / -3.56%
Today’s Change
1.65
Today|||52-Week Range
3.78
-32.40%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 4.70, with a high estimate of 7.00 and a low estimate of 2.40. The median estimate represents a +116.59% increase from the last price of 2.17.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$0.00
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.20%
 
 
 
 
 
 
Growthannually -151.92%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -99.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.